Trethera is a biotechnology company focused on the discovery and development of innovative small molecule cancer treatments that are based on precisely controlling DNA replication and its integrity

To discuss partnering opportunities that will enable access to our technology platform for identifying novel targets in the field of nucleotide metabolism, or for product co-development and combination treatment opportunities in hematological and solid tumors, please contact us.